Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001127602-20-018892)

Filing Details

Accession Number:: 0001127602-20-018892
Form Type:: 4/A
Zero Holdings:: No
Publication Time:: 2020-06-04 18:33:04
Reporting Period:: 2020-05-15

Accepted Time:: 2020-06-04 18:33:04
Original Submission Date:: 2020-05-19
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1682852	Moderna Inc.	MRNA	()	4/A

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1643746	H. Lorence Kim	C/O Moderna, Inc. 200 Technology Square Cambridge MA 02139	Chief Financial Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2020-05-15	2,600	$63.80	1,219,910	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct

Footnotes

This sale was effected pursuant to a Rule 10b5-1 trading plan adopted on December 28, 2018, as amended on September 18, 2019.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $63.27 to $64.22. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.